InnoTherapy Inc (KQ:246960) — Market Cap & Net Worth
Market Cap & Net Worth: InnoTherapy Inc (246960)
InnoTherapy Inc (KQ:246960) has a market capitalization of $10.27 Million (₩15.15 Billion) as of June 19, 2026. Listed on the KQ stock exchange, this Korea-based company holds position #26982 globally and #1969 in its home market, demonstrating a 0.22% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying InnoTherapy Inc's stock price ₩1784.00 by its total outstanding shares 8492482 (8.49 Million). Review InnoTherapy Inc debt and liabilities to assess the company's total debt and financial obligations.
InnoTherapy Inc Market Cap History: 2019 to 2026
InnoTherapy Inc's market capitalization history from 2019 to 2026. Data shows change from $79.42 Million to $10.27 Million (-27.60% CAGR).
Index Memberships
InnoTherapy Inc is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
Kosdaq Composite Index
KOSDAQ
|
$270.08 Billion | 0.00% | #1086 of 1384 |
|
Kosdaq Composite Index
KQ11
|
$270.08 Billion | 0.00% | #1086 of 1384 |
Weight: InnoTherapy Inc's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
InnoTherapy Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how InnoTherapy Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.01x
InnoTherapy Inc's market cap is 0.01 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2019 | $79.42 Million | $692.76 Million | -$3.99 Billion | 0.11x | N/A |
| 2020 | $95.25 Million | $596.19 Million | -$3.05 Billion | 0.16x | N/A |
| 2021 | $69.64 Million | $507.29 Million | -$5.03 Billion | 0.14x | N/A |
| 2022 | $49.26 Million | $369.78 Million | -$5.97 Billion | 0.13x | N/A |
| 2023 | $51.05 Million | $1.32 Billion | -$5.03 Billion | 0.04x | N/A |
| 2024 | $47.42 Million | $4.74 Billion | -$3.73 Billion | 0.01x | N/A |
Competitor Companies of 246960 by Market Capitalization
Companies near InnoTherapy Inc in the global market cap rankings as of June 19, 2026.
Key companies related to InnoTherapy Inc by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #147 globally with a market cap of $153.73 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #207 globally with a market cap of $117.79 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #234 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
- Medtronic PLC (NYSE:MDT): Ranked #247 globally with a market cap of $101.86 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #147 | Abbott Laboratories | NYSE:ABT | $153.73 Billion | $88.41 |
| #207 | Stryker Corporation | NYSE:SYK | $117.79 Billion | $307.80 |
| #234 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
| #247 | Medtronic PLC | NYSE:MDT | $101.86 Billion | $79.34 |
InnoTherapy Inc Historical Marketcap From 2019 to 2026
Between 2019 and today, InnoTherapy Inc's market cap moved from $79.42 Million to $ 10.27 Million, with a yearly change of -27.60%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | ₩10.27 Million | -22.43% |
| 2025 | ₩13.24 Million | -72.09% |
| 2024 | ₩47.42 Million | -7.10% |
| 2023 | ₩51.05 Million | +3.62% |
| 2022 | ₩49.26 Million | -29.26% |
| 2021 | ₩69.64 Million | -26.89% |
| 2020 | ₩95.25 Million | +19.93% |
| 2019 | ₩79.42 Million | -- |
End of Day Market Cap According to Different Sources
On Jun 19th, 2026 the market cap of InnoTherapy Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $10.27 Million USD |
| MoneyControl | $10.27 Million USD |
| MarketWatch | $10.27 Million USD |
| marketcap.company | $10.27 Million USD |
| Reuters | $10.27 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About InnoTherapy Inc
SCL Science Inc. produces medical hemostatic agents using biomimetic technology. Its products include BiMM (Bio-inspired Medical Materials) that reacts immediately with blood; Endoseal, which is used for specialized indication of gastrointestinal bleeding; InnoSeal, a hemostatic agent that is used in various surgical fields, such as cardiology, radiology, and neurosurgery; Jelly Seal, a hemostasi… Read more